方盛制药
(603998)
| 流通市值：43.95亿 | | | 总市值：43.95亿 |
| 流通股本：4.39亿 | | | 总股本：4.39亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,384,194,641.79 | 957,747,647.35 | 462,773,883.82 | 1,746,442,351.5 |
| 营业总成本 | 1,066,112,188.31 | 750,975,843.59 | 362,507,389.84 | 1,446,723,025.15 |
| 其他经营收益 | | | | |
| 营业利润 | 341,197,817.23 | 233,572,276.78 | 103,710,627.45 | 358,197,148.18 |
| 利润总额 | 340,820,408.69 | 233,324,833.05 | 103,637,395.83 | 353,240,974.73 |
| 净利润 | 290,125,415.31 | 198,972,079.21 | 87,860,749.44 | 302,635,591.07 |
| 每股收益 | | | | |
| 其他综合收益 | -889,357.52 | -577,961.81 | -323,131.29 | -197,943.06 |
| 综合收益总额 | 289,236,057.79 | 198,394,117.4 | 87,537,618.15 | 302,437,648.01 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,038,885,956.06 | 1,071,791,840.82 | 1,013,259,837.07 | 1,013,841,193.65 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,020,787,509.41 | 2,019,708,944.13 | 2,042,261,870.53 | 2,041,931,796.25 |
| 资产总计 | 3,059,673,465.47 | 3,091,500,784.95 | 3,055,521,707.6 | 3,055,772,989.9 |
| 流动负债: | | | | |
| 流动负债合计 | 1,098,399,426.43 | 1,130,075,743.59 | 1,120,232,885.4 | 1,150,446,404.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 90,165,976.42 | 93,342,647.13 | 99,873,787.04 | 102,502,339.78 |
| 负债合计 | 1,188,565,402.85 | 1,223,418,390.72 | 1,220,106,672.44 | 1,252,948,743.89 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,780,128,350.94 | 1,777,104,655.53 | 1,734,022,158.66 | 1,711,676,859.57 |
| 股东权益合计 | 1,871,108,062.62 | 1,868,082,394.23 | 1,835,415,035.16 | 1,802,824,246.01 |
| 负债和股东权益合计 | 3,059,673,465.47 | 3,091,500,784.95 | 3,055,521,707.6 | 3,055,772,989.9 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,390,206,096.29 | 982,214,455.46 | 485,096,127.74 | 1,848,435,273.21 |
| 经营活动现金流出小计 | 963,025,536.52 | 712,349,630.29 | 404,910,074.75 | 1,463,803,377.75 |
| 经营活动产生的现金流量净额 | 427,180,559.77 | 269,864,825.17 | 80,186,052.99 | 384,631,895.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 759,727,193.26 | 480,759,844.76 | 132,821,586.45 | 899,234,528.07 |
| 投资活动现金流出小计 | 842,926,730.07 | 567,339,754.33 | 186,221,722.18 | 817,516,244.11 |
| 投资活动产生的现金流量净额 | -83,199,536.81 | -86,579,909.57 | -53,400,135.73 | 81,718,283.96 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 298,198,267.88 | 294,198,267.88 | 181,065,375 | 386,020,336 |
| 筹资活动现金流出小计 | 719,785,703.12 | 516,362,339.64 | 264,966,630.18 | 880,131,386.57 |
| 筹资活动产生的现金流量净额 | -421,587,435.24 | -222,164,071.76 | -83,901,255.18 | -494,111,050.57 |
| 汇率变动对现金及现金等价物的影响 | -75,423.87 | -64,825.9 | -23,830.36 | -90,882.9 |
| 现金及现金等价物净增加额 | -77,681,836.15 | -38,943,982.06 | -57,139,168.28 | -27,851,754.05 |
| 期末现金及现金等价物余额 | 190,488,442.55 | 229,226,296.64 | 214,220,151.24 | 268,170,278.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -38,943,982.06 | - | -27,851,754.05 |
最新报告期：2026-09-11| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中邮证券 | 盛丽华,龙永茂 | 0.84 | 1.01 | 1.21 | 2026-09-11 |
| 开源证券 | 余汝意,巢舒然 | 0.84 | 1.01 | 1.21 | 2026-08-31 |
| 华泰证券 | 代雯,唐庆雷,张云逸 | 0.83 | 0.99 | 1.17 | 2026-08-31 |
| 东吴证券 | 向潇,朱国广 | 0.84 | 1.02 | 1.25 | 2026-08-30 |